Εμφανίζονται 1 - 17 Αποτελέσματα από 17 για την αναζήτηση '"функциональная патология"', χρόνος αναζήτησης: 0,62δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Πηγή: Meditsinskiy sovet = Medical Council; № 23 (2024); 104-111 ; Медицинский Совет; № 23 (2024); 104-111 ; 2658-5790 ; 2079-701X

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/8833/7742; Ивашкин ВТ, Маев ИВ, Трухманов АС, Лапина ТЛ, Сторонова ОА, Зайратьянц ОВ и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(4):70–97. https://doi.org/10.22416/1382-4376-2020-30-4-70-97.; Li N, Yang WL, Cai MH, Chen X, Zhao R, Li MT et al. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of disease study 2019. BMC Public Health. 2023;23(1):582. https://doi.org/10.1186/s12889-023-15272-z.; Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440. https://doi.org/10.1136/gutjnl-2016-313589.; El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–880. https://doi.org/10.1136/gutjnl-2012-304269.; Лазебник ЛБ, Машарова АА, Бордин ДС, Васильев ЮВ, Ткаченко ЕИ, Абдулхаков РА и др. Результаты многоцентрового исследования «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» (МЭГРЕ). Терапевтический архив. 2011;83(1):45–50. Режим доступа: https://elibrary.ru/ntmfzf.; Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT. Bile reflux gastritis and Barrett’s oesophagus: further evidence of a role for duodenogastroesophageal reflux? Gut. 2001;49(3):359–363. https://doi.org/10.1136/gut.49.3.359.; Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;150(6):1393–1407.e5. https://doi.org/10.1053/j.gastro.2016.02.031.; Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.e4. https://doi.org/10.1016/j.cgh.2012.02.029.; Ford AC, Forman D, Bailey AG. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol. 2008;103(5):1229–1239. Available at: https://journals.lww.com/ajg/Abstract/2008/05000/Irritable_Bowel_SyndromeA_10_Yr_Natural_History.25.aspx.; Симаненков ВИ, Маев ИВ, Ткачева ОН, Алексеенко СА, Андреев ДН, Бордин ДС и др. Синдром повышенной эпителиальной проницаемости в клинической практике. Мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):2758. https://doi.org/10.15829/1728-8800-2021-2758.; Ивашкин ВТ, Маев ИВ, Шелыгин ЮА, Баранская ЕК, Белоус СС, Белоусова ЕА и др. Диагностика и лечение синдрома раздраженного кишечника (Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(5):74–95. https://doi.org/10.22416/1382-4376-2021-31-5-74-95.; Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010;8(5):401–409. https://doi.org/10.1016/j.cgh.2009.07.020.; Rasmussen S, Jensen TH, Henriksen SL, Haastrup PF, Larsen PV, Søndergaard J, Jarbøl DE. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scand J Gastroenterol. 2015;50(2):162–169. https://doi.org/10.3109/00365521.2014.983157.; Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome: a population-based study. Digestion. 2009;79(3):196–201. https://doi.org/10.1159/000211715.; de Bortoli N, Martinucci I, Bellini M, Savarino E, Savarino V, Blandizzi C, Marchi S. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol. 2013;19(35):5787–5797. https://doi.org/10.3748/wjg.v19.i35.5787.; Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol. 2012;107(12):1793–1801. https://doi.org/10.1038/ajg.2012.336.; Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;150(6):1262–1279.e2. https://doi.org/10.1053/j.gastro.2016.02.032.; Stanghellini V, Barbara G, Cogliandro R, Salvioli B, Cremon C, De Giorgio R, Corinaldesi R. Overlap between GERD and IBS: irrefutable but subtle. J Clin Gastroenterol. 2007;41:S114–S117. https://doi.org/10.1097/MCG.0b013e31803d0f94.; Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ. 1992;304(6819):87–90. https://doi.org/10.1136/bmj.304.6819.87.; de Bortoli N, Natali V, Melissari S, Simonetti N, Tapete G, Marchi S. Overlap of GERD and gastrointestinal functional disorders. Minerva Gastroentrol Dietol. 2017;63(3):205–220. https://doi.org/10.23736/S1121-421X.17.02398-4.; Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–328. https://doi.org/10.1038/ajg.2012.444.; Gunaratnam NT, Jessup TP, Inadomi J, Lascewski DP. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastrooesophageal reflux disease. Aliment Pharmacol Ther. 2006;23(10):1473–1477. https://doi.org/10.1111/j.1365-2036.2006.02911.x.; Garros A, Mion F, Marjoux S, Damon H, Roman S. Factors associated with nonresponse to proton pump inhibitors therapy in patients referred for esophageal pH-impedance monitoring. Dis Esophagus. 2016;29(7):787–793. https://doi.org/10.1111/dote.12374.; Mönnikes H, Heading RC, Schmitt H, Doerfler H. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol. 2011;17(27):3235–3241. Available at: https://www.wjgnet.com/1007-9327/full/v17/i27/3235.htm.; Kinoshita Y, Miwa H, Sanada K, Miyata K, Haruma K. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. J Gastroenterol. 2014;49(4):628–637. https://doi.org/10.1007/s00535-013-0812-3.; Mönnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Sander P, Lühmann R. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2012;35(11):1279–1289. https://doi.org/10.1111/j.1365-2036.2012.05085.x.; Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8(6):504–508. https://doi.org/10.1016/j.cgh.2009.12.022.; Van den Houte K, Colomier E, Routhiaux K, Mariën Z, Schol J, Van den Bergh J et al. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome. Gastroenterology. 2024;167(2):333–342. https://doi.org/10.1053/j.gastro.2024.02.008.; de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol. 2018;31(6):639–648. https://doi.org/10.20524/aog.2018.0314.; Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Lawrence R Schiller et al. American College of Gastroenterilogy monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl. 1):S2–S26. https://doi.org/10.1038/ajg.2014.187.; Буторова ЛИ, Токмулина ГМ, Плавник ТЭ, Рассыпнова ЛИ, Мамиева ЗА. Римские критерии IV синдрома раздраженного кишечника: эволюция взглядов на патогенез, диагностику и лечение. Лечащий врач. 2017;(3):61–64. Режим доступа: https://www.lvrach.ru/2017/03/15436690.; Kountouras J, Chatzopoulos D, Zavos C, Boura P, Venizelos J, Kalis A. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology. 2002;49(43):193–197. Available at: https://pubmed.ncbi.nlm.nih.gov/11941952/.; Ивашкин ВТ, Трухманов АС, Гоник МИ. Применение ребамипида в лечении гастроэзофагеальной рефлюксной болезни. Терапевтический архив. 2020;92(4):98–104. https://doi.org/10.26442/00403660.2020.04.000568.; Исаков ВА. Ингибиторы протонного насоса: их свойства и применение в гастроэнтерологии. М.: Академкнига; 2001. 304 с. Режим доступа: https://elibrary.ru/wkasaj.; Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs. 1996;51(3):460–482. https://doi.org/10.2165/00003495-199651030-00012.; Koop H, Kuly S, Flüg M, Eissele R, Mönnikes H, Rose K et al. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects. Eur J Gastroenterol Hepatol. 1996;8(9):915–918. Available at: https://pubmed.ncbi.nlm.nih.gov/8889461/.; Corinaldesi R, Valentini M, Belaïche J, Colin R, Geldof H, Maier C. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment Pharmacol Ther. 1995;9(6):667–671. https://doi.org/10.1111/j.1365-2036.1995.tb00437.x.; Brunner G, Athmann C, Schneider A. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease. Aliment Pharmacol Ther. 2012;36(1):37–47. https://doi.org/10.1111/j.1365-2036.2012.05106.x.

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Academic Journal

    Περιγραφή αρχείου: application/pdf

    Relation: Синдром подразненого кишечника у дітей: етіопатогенетичні аспекти та напрямки терапії / Т. Ю. Кравченко, Г. К. Копійка, Н. Ю. Горностаєва та ін. // Актуальні проблеми сучасної медицини. – 2016. – Т. 16, № 2. – С. 286–293.; http://repo.odmu.edu.ua:80/xmlui/handle/123456789/4004

  17. 17